Atox Bio Competitors and Similar CompaniesClear all
Atox Bio's competitors and similar companies include Triumvira, Polyplus-transfection, Codiak Biosciences and Acorda Therapeutics.
 Atox Bio Atox Bio is a critical care immunotherapy company focusing on acute, life-threatening, conditions. |  Polyplus-transfection Polyplus-transfection is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction, and therapeutics. |  Codiak Biosciences Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics. |  Acorda Therapeutics Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders. | ||
Founding Date | Founding Date 2003 | Founding Date 2015 | Founding Date 2002 | Founding Date 2015 | Founding Date 1995 |
Type | Type Private | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Durham, US HQ Ness Ziona, IL | Locations Austin, US HQ Hamilton, CA | Locations Illkirch-Graffenstaden, FR HQ New York, US | Locations Cambridge, US HQ | Locations Ardsley, US HQ Chelsea, US South San Francisco, US Waltham, US |
Employees | Employees 910% decrease | Employees 287% decrease | Employees 1133% increase | Employees 992% decrease | Employees 4742% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 2.8 m | Valuation ($) 821 k |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $22.9m (FY, 2021) | Revenue (est.) $117.6m (FY, 2023) |
Net income | Net income N/A | Net income N/A | Net income N/A | Net income ($37.2m) (FY, 2021) | Net income ($252.9m) (FY, 2023) |
Funding | |||||
Latest funding round | Latest funding round $ 30m (over 8 years ago) | Latest funding round $ 55m (almost 6 years ago) | Latest funding round $ 3.2m (over 15 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 56.3m | Total funding raised $ 55m | Total funding raised $ 3.2m | Total funding raised $ 168.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Triumvira
HQ
Austin, US
Employees
28↓ 7% decrease
Triumvira Immunologics is an immunotherapy company.
View companyPolyplus-transfection
HQ
Illkirch-Graffenstaden, FR
Employees
113↑ 3% increase
Polyplus-transfection is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction, and therapeutics.
View companyCodiak Biosciences
HQ
Cambridge, US
Employees
99↓ 2% decrease
Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.
View companyAcorda Therapeutics
HQ
Ardsley, US
Employees
474↓ 2% decrease
Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.
View company